| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9220876 | Sleep Medicine | 2005 | 7 Pages |
Abstract
The open-label trial of long-term hypnotic therapy with zaleplon 5 and 10Â mg suggests that they are safe and effective for the treatment of insomnia in older patients. Placebo-controlled, double-blind trials are needed in zaleplon and other BzRAs to confirm these results.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Sonia Ancoli-Israel, Gary S. Richardson, Richard M. Mangano, Lisa Jenkins, Phil Hall, Walter S. Jones,